In the literature, blood‐derived macrophages from healthy donors, or patients with IBD, displayed a CD206+CCL18+CD14low/−phenotype upon IL‐4 treatment, thus acquiring the ability to accelerate epithelial wound healing by producing TGF‐β.75 Here, MRC1 is linked to inflammatory bowel disease.